Concepedia

Atomoxetine Augmentation

Atomoxetine Augmentation is a pharmacotherapeutic strategy involving the addition of atomoxetine to a primary stimulant regimen to enhance treatment efficacy in individuals with attention-deficit/hyperactivity disorder who exhibit suboptimal response to stimulants alone.

162

Publications

9.3K

Citations

761

Authors

331

Institutions

Publications per year

2017–2026

30

Parents

Publications

162

Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

Frank P. Bymaster · Neuropsychopharmacology · 2002 · 1.1K citations · Full text

, , +17

Relapse Prevention in Pediatric Patients With ADHD Treated With Atomoxetine: A Randomized, Double-Blind, Placebo-Controlled Study

David Michelson, Jan K. Buitelaar, Marina Danckaerts et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2004 · 308 citations

, , +17

Atomoxetine Improved Response Inhibition in Adults with Attention Deficit/Hyperactivity Disorder

Samuel R. Chamberlain, Natalia del Campo, J. H. Dowson et al. · Biological Psychiatry · 2007 · 284 citations

, , +14

Atomoxetine for Hyperactivity in Autism Spectrum Disorders: Placebo-Controlled Crossover Pilot Trial

L. Eugene Arnold, Michael G. Aman, AMELIA M. COOK et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2006 · 261 citations

, , +12

Emotional Dysregulation in Adult ADHD and Response to Atomoxetine

Frederick W. Reimherr, Barrie K. Marchant, Robert E. Strong et al. · Biological Psychiatry · 2005 · 257 citations

, , +14

1–5 of 162

Authors

761

  1. MG
    Michael G. Aman

    The Ohio State University, United States

    10 publications · 600 citations

    10

    h-index

  2. LE
    L. Eugene Arnold

    The Ohio State University, United States

    9 publications · 573 citations

    9

    h-index

  3. AJ
    Albert J. Allen

    Eli Lilly (United States), United States

    8 publications · 508 citations

    8

    h-index

  4. AS
    Alexander Schacht

    Eli Lilly (Germany), Germany

    8 publications · 340 citations

    8

    h-index

  5. DK
    Douglas K. Kelsey

    Eli Lilly (United States), United States

    8 publications · 702 citations

    8

    h-index

1–5 of 761

Institutions

331

  1. Eli Lilly (United States)

    Indianapolis, United States

    25 h-index

    121 publications

    10.9K citations

  2. Massachusetts General Hospital

    Boston, United States

    12 h-index

    62 publications

    7.5K citations

  3. The Ohio State University

    Columbus, United States

    10 h-index

    50 publications

    2K citations

  4. Eli Lilly (Germany)

    Bad Homburg, Germany

    10 h-index

    25 publications

    660 citations

  5. University of Pittsburgh

    Pittsburgh, United States

    8 h-index

    16 publications

    710 citations

  6. Heidelberg University

    Heidelberg, Germany

    7 h-index

    15 publications

    431 citations

  7. Harvard University

    Cambridge, United States

    7 h-index

    40 publications

    2.5K citations

  8. Indiana University – Purdue University Indianapolis

    Indianapolis, United States

    7 h-index

    21 publications

    2.5K citations

1–8 of 331

Venues

  1. 14

    h-index

  2. Journal of Child and Adolescent Psychopharmacology

    JCAP · 14 publications · 505 citations

    14

    h-index

  3. 5

    h-index

  4. Psychopharmacology

    5 publications · 151 citations

    5

    h-index

  5. Biological Psychiatry

    5 publications · 732 citations

    5

    h-index

1–5